ArticleFrontiers in psychiatry2025
Comparing plasma levels and ratios of tryptophan, serotonin, kynurenine and quinolinic acid between patients with bipolar disorder and healthy controls: impact of depressive episode or post-traumatic stress disorder symptoms.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Allostatic and Circadian Drives in Patients with Bipolar Disorder in Depressive Episodes or with Post-Traumatic Stress Disorder Versus Healthy Controls: Neuroendocrine Comparison Through Cortisol and 6-Sulfatoxymelatonin Overnight Urine Excretion.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bipolar disorder (BD) is a chronic mental illness displaying recurrent episodes of impaired mood, in alternance with euthymic or subsyndromal periods. The comorbidity between BD and post-traumatic stress disorder (PTSD) is attracting attention due to its frequency, diagnostic difficulties, and worsening prognosis. Consequently, identifying molecular substrates of post-traumatic vs. depressive symptoms in BD would provide much benefit for patients' rescue. This study thus focused on tryptophan (TRP) metabolism, at the crossroad between neurotransmission, immunity and inflammation, under distinct BD mental conditions. Methods: We compared plasma TRP, serotonin (5-HT), kynurenine (KYN) and quinolinic acid (QUIN) among 20 euthymic-BD patients with PTSD (PTSD group) or 20 with depressive episode (DEP group) and 24 controls (CTL group). Metabolic ratios were calculated to monitor TRP-path fluxes. All participants underwent clinical examinations by psychometric instruments as the: Structured Clinical Interview for DSM-5 disorders (SCID-5), Hamilton Depression Rating Scale (HAM-D), Young Mania Rating Scale (YMRS), Impact of Event Scale-Revised (IES-R), Mood Spectrum-Self-Report lifetime version (MOODS-SR), Trauma and Loss Spectrum-Self Report lifetime version (TALS-SR), Work and Social Adjustment Scale (WSAS). Blood withdraws were also achieved, followed by plasma measurements through ELISA. Results: Both DEP and PTSD-groups revealed markedly lower 5-HT and 5-HT/TRP values than controls, with additionally decreased 5-HT in DEP- vs. PTSD-subjects. DEP-patients also showed reduced TRP and increased QUIN, KYN and QUIN ratios vs controls, while PTSD-subjects displaying only increased QUIN/KYN values. Additionally, several correlations between biochemical and clinical parameters were reported. Noteworthy, 5-HT and 5-HT/TRP were negatively correlated with all psychometric measures, while all biochemical parameters studied, except KYN, were correlated with poor socio-personal functioning; otherwise, KYN-shunt parameters better distinguished the severity of DEP symptoms than the PTSD ones. Conclusions: Substantially, BD-patients with low 5-HT and severe burden could be distinguished based on KYN profiles/trajectories when affected by depression or PTSD, entailing different neuroinflammatory/neuroendocrine patterns in mood vs. post-traumatic stress dimensions. This will encourage deeper assessment of BD metabolic/inflammatory biomarkers, allowing for refined patients' stratifications and targeted therapeutic interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.